Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, <scp>EMT</scp> nor metastatic spread in colorectal cancer-Reference-Cited by-同舟云学术

Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer

Published:2022-11-08 Issue:1 Volume:9 Page:73-85
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:The Journal of Pathology CR

Author:

Jaitner Stefanie¹,Pretzsch Elise²³,Neumann Jens¹³,Schäffauer Achim¹,Schiemann Matthias⁴⁵,Angele Martin²,Kumbrink Jörg¹³,Schwitalla Sarah⁶,Greten Florian R³⁶,Brandl Lydia¹,Klauschen Frederick¹³,Horst David⁷⁸,Kirchner Thomas¹³,Jung Andreas¹³

Affiliation:

1. Institute of Pathology, Faculty of Medicine Ludwig‐Maximilians‐Universität München Munich Germany

2. Department of General, Visceral, and Transplant Surgery Ludwig‐Maximilians‐Universität München Munich Germany

3. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Munich Heidelberg Germany

4. Institute of Medical Microbiology, Immunology and Hygiene Technische Universität München Munich Germany

5. Clinical Cooperation Group Immune Monitoring, Helmholtz Center Munich (Neuherberg) and Technische Universität München Munich Germany

6. Georg‐Speyer‐Haus Institute for Tumor Biology and Experimental Therapy Frankfurt Germany

7. Institute of Pathology, Charité‐Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt‐Universität zu Berlin and Berlin Institute of Health Berlin Germany

8. German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ) Heidelberg Germany

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.300

Reference56 articles.

1. Colorectal cancer

2. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

3. Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges

4. A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer

5. Cancer Stem Cell Markers Are Associated With Distant Hematogenous Liver Metastases But Not With Peritoneal Carcinomatosis in Colorectal Cancer